title: Mapping molecular differences and extracellular matrix gene expression in segmental outflow pathways of the human ocular trabecular meshwork.
abstract: Elevated intraocular pressure (IOP) is the primary risk factor for glaucoma, and lowering IOP remains the only effective treatment for glaucoma. The trabecular meshwork (TM) in the anterior chamber of the eye regulates IOP by generating resistance to aqueous humor outflow. Aqueous humor outflow is segmental, but molecular differences between high and low outflow regions of the TM are poorly understood. In this study, flow regions of the TM were characterized using fluorescent tracers and PCR arrays. Anterior segments from human donor eyes were perfused at physiological pressure in an ex vivo organ culture system. Fluorescently-labeled microspheres of various sizes were perfused into anterior segments to label flow regions. Actively perfused microspheres were segmentally distributed, whereas microspheres soaked passively into anterior segments uniformly labeled the TM and surrounding tissues with no apparent segmentation. Cell-tracker quantum dots (20 nm) were localized to the outer uveal and corneoscleral TM, whereas larger, modified microspheres (200 nm) localized throughout the TM layers and Schlemm's canal. Distribution of fluorescent tracers demonstrated a variable labeling pattern on both a macro- and micro-scale. Quantitative PCR arrays allowed identification of a variety of extracellular matrix genes differentially expressed in high and low flow regions of the TM. Several collagen genes (COL16A1, COL4A2, COL6A1 and 2) and MMPs (1, 2, 3) were enriched in high, whereas COL15A1, and MMP16 were enriched in low flow regions. Matrix metalloproteinase activity was similar in high and low regions using a quantitative FRET peptide assay, whereas protein levels in tissues showed modest regional differences. These gene and protein differences across regions of the TM provide further evidence for a molecular basis of segmental flow routes within the aqueous outflow pathway. New insight into the molecular mechanisms of segmental aqueous outflow may aid in the design and delivery of improved treatments for glaucoma patients.
authors.affiliation: Casey Eye Institute, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd, Portland, Oregon, United States of America.
authors.forename: Janice A
authors.initials: JA
authors.lastname: Vranka
authors.affiliation: Casey Eye Institute, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd, Portland, Oregon, United States of America.
authors.forename: John M
authors.initials: JM
authors.lastname: Bradley
authors.affiliation: Casey Eye Institute, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd, Portland, Oregon, United States of America.
authors.forename: Yong-Feng
authors.initials: YF
authors.lastname: Yang
authors.affiliation: Casey Eye Institute, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd, Portland, Oregon, United States of America.
authors.forename: Kate E
authors.initials: KE
authors.lastname: Keller
authors.affiliation: Casey Eye Institute, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd, Portland, Oregon, United States of America.
authors.forename: Ted S
authors.initials: TS
authors.lastname: Acott
mesh_terms: D016326:Extracellular Matrix Proteins / Q000235:genetics*; D020869:Gene Expression Profiling; D006801:Humans; D020782:Matrix Metalloproteinases / Q000378:metabolism; D008863:Microspheres; D014129:Trabecular Meshwork / Q000201:enzymology / Q000378:metabolism*
chemical_list: D016326:Extracellular Matrix Proteins; D020782:Matrix Metalloproteinases
references.citation: Exp Eye Res. 2006 Apr;82(4):545-57
references.pmid: 16386733
references.citation: Invest Ophthalmol Vis Sci. 2013 Mar;54(3):2035-47
references.pmid: 23422826
references.citation: Invest Ophthalmol Vis Sci. 2007 Mar;48(3):1164-72
references.pmid: 17325160
references.citation: Invest Ophthalmol Vis Sci. 2000 Sep;41(10):2984-90
references.pmid: 10967055
references.citation: Invest Ophthalmol Vis Sci. 2003 Nov;44(11):4796-804
references.pmid: 14578401
references.citation: Exp Eye Res. 2011 Oct;93(4):397-404
references.pmid: 21669200
references.citation: Mol Vis. 2013;19:1639-55
references.pmid: 23901248
references.citation: AMA Arch Ophthalmol. 1956 Feb;55(2):193-204
references.pmid: 13282544
references.citation: JAMA Ophthalmol. 2013 Oct;131(10):1265-6
references.pmid: 23949187
references.citation: Arch Ophthalmol. 1989 Apr;107(4):572-6
references.pmid: 2705927
references.citation: Invest Ophthalmol Vis Sci. 2012;53(8):4616-25
references.pmid: 22695958
references.citation: Invest Ophthalmol Vis Sci. 1991 Jan;32(1):172-80
references.pmid: 1846130
references.citation: Invest Ophthalmol Vis Sci. 2001 Jul;42(8):1795-802
references.pmid: 11431444
references.citation: Curr Eye Res. 2002 Nov;25(5):299-308
references.pmid: 12658549
references.citation: Invest Ophthalmol Vis Sci. 2008 Dec;49(12):5346-52
references.pmid: 18515571
references.citation: Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1968;176(4):309-29
references.pmid: 5305008
references.citation: Mol Vis. 2006;12:774-90
references.pmid: 16862071
references.citation: Exp Eye Res. 2009 Apr;88(4):676-82
references.pmid: 19087875
references.citation: Invest Ophthalmol Vis Sci. 2013 May;54(5):3309-19
references.pmid: 23599341
references.citation: Invest Ophthalmol Vis Sci. 2005 Jan;46(1):1-7
references.pmid: 15623746
references.citation: Invest Ophthalmol Vis Sci. 1994 Oct;35(11):3841-51
references.pmid: 7928181
references.citation: Invest Ophthalmol Vis Sci. 2013;54(8):5613-23
references.pmid: 23882691
references.citation: Exp Eye Res. 2012 Mar;96(1):82-7
references.pmid: 22210126
references.citation: Invest Ophthalmol Vis Sci. 2006 Mar;47(3):794-801
references.pmid: 16505009
references.citation: Sci Rep. 2013;3:1365
references.pmid: 23455567
references.citation: Exp Eye Res. 2008 Feb;86(2):271-81
references.pmid: 18155193
references.citation: Curr Opin Ophthalmol. 2012 Mar;23(2):135-43
references.pmid: 22262082
references.citation: Exp Eye Res. 2015 Apr;133:112-25
references.pmid: 25819459
references.citation: Invest Ophthalmol Vis Sci. 2011 Jul;52(8):5049-57
references.pmid: 21596823
references.citation: Mol Vis. 2005;11:603-8
references.pmid: 16110303
references.citation: Proc Natl Acad Sci U S A. 2014 Sep 23;111(38):13876-81
references.pmid: 25201985
references.citation: Acta Physiol Scand. 1954;30(2-3):240-8
references.pmid: 13158098
references.citation: Invest Ophthalmol Vis Sci. 1985 Jun;26(6):797-804
references.pmid: 3891665
references.citation: Exp Eye Res. 1986 Aug;43(2):273-8
references.pmid: 3758226
references.citation: Invest Ophthalmol Vis Sci. 2013 Sep;54(9):6382-9
references.pmid: 24003086
references.citation: Exp Eye Res. 2002 Sep;75(3):347-58
references.pmid: 12384097
references.citation: J Ocul Biol. 2013 Jun;1(1):3
references.pmid: 24364042
references.citation: Acta Histochem Cytochem. 2007 Aug 30;40(4):101-11
references.pmid: 17898874
references.citation: Invest Ophthalmol Vis Sci. 1998 Dec;39(13):2649-58
references.pmid: 9856774
references.citation: Invest Ophthalmol Vis Sci. 1991 Jan;32(1):160-71
references.pmid: 1987099
references.citation: Invest Ophthalmol Vis Sci. 2008 Jun;49(6):2495-505
references.pmid: 18515587
references.citation: Exp Eye Res. 1991 Jun;52(6):723-31
references.pmid: 1855546
references.citation: Chin Med J (Engl). 2010 Mar 5;123(5):599-605
references.pmid: 20367989
references.citation: Invest Ophthalmol Vis Sci. 2011 Apr;52(5):2147-52
references.pmid: 21220561
references.citation: Invest Ophthalmol Vis Sci. 2010 Jun;51(6):3029-41
references.pmid: 20089870
references.citation: Arch Ophthalmol. 1963 Jun;69:783-801
references.pmid: 13949877
references.citation: Chin Med J (Engl). 2013;126(8):1451-7
references.pmid: 23595376
references.citation: J Ocul Pharmacol Ther. 2014 Mar-Apr;30(2-3):291-9
references.pmid: 24611521
references.citation: Exp Eye Res. 2011 Feb;92(2):104-11
references.pmid: 21187085
references.citation: Arch Ophthalmol. 1989 Feb;107(2):250-4
references.pmid: 2916978
references.citation: Exp Eye Res. 2002 Feb;74(2):161-72
references.pmid: 11950226
references.citation: J Ocul Pharmacol Ther. 2014 Mar-Apr;30(2-3):213-23
references.pmid: 24456518
references.citation: Am J Ophthalmol. 1955 Apr;39(4 Pt 2):65-89
references.pmid: 14361607
references.citation: Exp Eye Res. 2009 Apr;88(4):648-55
references.pmid: 19239914
references.citation: Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5116-21
references.pmid: 11309499
references.citation: J Glaucoma. 2013 Sep;22(7):517-25
references.pmid: 22828004
references.citation: Invest Ophthalmol Vis Sci. 2005 Aug;46(8):2857-68
references.pmid: 16043860
references.citation: Exp Eye Res. 2008 Apr;86(4):543-61
references.pmid: 18313051
references.citation: J Ultrastruct Res. 1972 Mar;38(5):500-10
references.pmid: 4111070
references.citation: Invest Ophthalmol Vis Sci. 2009 Apr;50(4):1692-7
references.pmid: 19060275
references.citation: Graefes Arch Clin Exp Ophthalmol. 2001 Feb;239(2):138-44
references.pmid: 11372544
references.citation: J Biol Chem. 2005 Feb 18;280(7):6080-4
references.pmid: 15579465
references.citation: Mol Vis. 2005;11:425-30
references.pmid: 15988411
references.citation: Invest Ophthalmol Vis Sci. 2011 Jan;52(1):45-50
references.pmid: 20720231
references.citation: Invest Ophthalmol Vis Sci. 2009 Dec;50(12):5769-77
references.pmid: 19553617
references.citation: Invest Ophthalmol Vis Sci. 2001 Jun;42(7):1505-13
references.pmid: 11381054
references.citation: Clin Genet. 2013 Aug;84(2):167-74
references.pmid: 23621901
references.citation: Prog Retin Eye Res. 1999 Jan;18(1):91-119
references.pmid: 9920500